Safety and efficacy of carboplatin plus nab-paclitaxel for treating advanced non-small-cell lung cancer with interstitial lung disease

There are few established treatments for patients with non-small-cell lung cancer (NSCLC) with interstitial lung disease (ILD). The safety and efficacy of albumin-bound paclitaxel (nab-paclitaxel) in combination with carboplatin is uncertain, although the combination of carboplatin and paclitaxel is...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Mol Clin Oncol
Autores principales: Niwa, Hideyuki, Nakahara, Yoshiro, Yokoba, Masanori, Mitsufuji, Hisashi, Sasaki, Jiichiro, Masuda, Noriyuki
Formato: Artigo
Lenguaje:Inglês
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5574118/
https://ncbi.nlm.nih.gov/pubmed/28855994
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2017.1359
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares